Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
60 hedge funds and large institutions have $121M invested in Applied Genetic Technologies Corporation in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 9 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
5% less funds holding
Funds holding: 63 → 60 (-3)
15% less capital invested
Capital invested by funds: $143M → $121M (-$22M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$9.12M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.16M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.01M |
| 4 |
SIM
Spark Investment Management
New York
|
+$1.42M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$8.74M |
| 2 |
Jennison Associates
New York
|
-$6.1M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.07M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$803K |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$415K |
AGTC Hedge Fund Activity: Q3 2015 in Review
60 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2015, worth a combined $121M — down 15% from $143M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AGTC and 6 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 26 added.
The largest buyer was Perceptive Advisors, adding an estimated $9.12M. The largest seller was Acuta Capital Partners, cutting an estimated $8.74M.
- 60 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2015, down from 63 in Q2 2015.
- Funds reported $121M of Applied Genetic Technologies Corporation stock for Q3 2015, down 15% quarter-over-quarter.
- 6 funds opened new Applied Genetic Technologies Corporation positions in Q3 2015 and 9 closed out, a net change of -3 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2015 was Perceptive Advisors, an estimated $9.12M added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2015 was Acuta Capital Partners, an estimated $8.74M sold.
Based on aggregated 13F filings for Q3 2015.